Last Week Of Fun In The Markets? Click to watch.

Aurinia Pharmaceuticals Inc Stock Forecast

NASDAQ:AUPH BUY SELL

$10.05 (-2.24%)

Volume: 1.35M

Closed: Jun 30, 2022

Hollow Logo Score: -2.274

Aurinia Pharmaceuticals Inc Stock Forecast

BUY SELL NASDAQ:AUPH
$10.05 (-2.24%)

Volume: 1.35M

Closed: Jun 30, 2022

Score Hollow Logo -2.274

AUPH Price Targets and Analyst Ratings NASDAQ:AUPH

Historical Ratings and Targets

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-05-05 148.76% Cantor Fitzgerald $25.00 Assumes Overweight
2022-05-05 198.51% HC Wainwright & Co. $33.00 $30.00 Maintains Buy
2022-04-28 118.91% RBC Capital $27.00 $22.00 Maintains Outperform
2022-03-08 118.91% SVB Leerink $30.00 $22.00 Maintains Outperform
2022-03-01 168.66% RBC Capital $31.00 $27.00 Maintains Outperform
2022-02-23 208.46% RBC Capital $34.00 $31.00 Maintains Outperform
2021-12-10 208.46% Oppenheimer $33.00 $31.00 Upgrades Perform Outperform
2021-11-04 298.01% HC Wainwright & Co. $35.00 $40.00 Maintains Buy
2021-11-04 248.26% SVB Leerink $28.00 $35.00 Maintains Outperform
2021-11-04 228.36% Oppenheimer $32.00 $33.00 Maintains Perform
2021-10-28 218.41% Oppenheimer $28.00 $32.00 Downgrades Outperform Perform
2021-10-26 238.31% RBC Capital $23.00 $34.00 Maintains Outperform
2021-01-27 178.61% SVB Leerink $24.00 $28.00 Maintains Outperform
2021-01-25 248.26% HC Wainwright & Co. $30.00 $35.00 Maintains Buy
2020-11-03 178.61% HC Wainwright & Co. $34.00 $28.00 Maintains Buy
2020-08-12 238.31% HC Wainwright & Co. $33.00 $34.00 Maintains Buy
2020-07-22 228.36% HC Wainwright & Co. $32.00 $33.00 Maintains Buy
2020-03-06 218.41% Cantor Fitzgerald $30.00 $32.00 Maintains Overweight
2019-12-16 218.41% HC Wainwright & Co. $25.00 $32.00 Maintains Buy
2019-09-10 39.3% Oppenheimer $14.00 Initiates Coverage On Outperform

AUPH Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -7.59% during the next 3 months and, with a 90% probability hold a price between $7.71 and $11.60 at the end of this 3-month period.

Data

Date Bottom Mid Top
2022-07-05 $8.33 $10.43 $12.53
2022-07-06 $8.31 $10.42 $12.52
2022-07-07 $8.30 $10.40 $12.50
2022-07-08 $8.28 $10.38 $12.48
2022-07-11 $8.26 $10.37 $12.47
2022-07-12 $8.25 $10.35 $12.45
2022-07-13 $8.23 $10.33 $12.43
2022-07-14 $8.21 $10.32 $12.42
2022-07-15 $8.20 $10.30 $12.40
2022-07-18 $8.18 $10.28 $12.38
2022-07-19 $8.16 $10.27 $12.37
2022-07-20 $8.15 $10.25 $12.35
2022-07-21 $8.13 $10.23 $12.33
2022-07-22 $8.11 $10.22 $12.32
2022-07-25 $8.10 $10.20 $12.30
2022-07-26 $8.08 $10.18 $12.28
2022-07-27 $8.06 $10.17 $12.27
2022-07-28 $8.05 $10.15 $12.25
2022-07-29 $8.03 $10.13 $12.23
2022-08-01 $8.01 $10.12 $12.22
2022-08-02 $8.00 $10.10 $12.20
2022-08-03 $7.98 $10.08 $12.18
2022-08-04 $7.96 $10.07 $12.17
2022-08-05 $7.95 $10.05 $12.15
2022-08-08 $7.93 $10.03 $12.13
2022-08-09 $7.91 $10.02 $12.12
2022-08-10 $7.90 $10.00 $12.10
2022-08-11 $7.88 $9.98 $12.08
2022-08-12 $7.86 $9.97 $12.07
2022-08-15 $7.85 $9.95 $12.05

IMPROVE YOUR TRADING GAME WITH A GOLDEN STAR

From 27 541 stocks, only a few dozen will trigger such a signal!

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Aurinia Pharmaceuticals Inc., a clinical stage pharmaceutical company, engages in the development of a therapeutic drug to treat autoimmune diseases in Canada. The company’s lead drug candidate is Voclosporin, a calcineurin inhibitor, which is in Phase IIb clinical trial for the treatment of lupus nephritis. It has a collaboration agreement with Paladin Labs Inc. to maintain the patent portfolio for Voclosporin in Canada, South Africa, and Israe... Read more

.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT